Profile	GDS4460 / 213388_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	75.4	64
GSM803589	patient 7, baseline	116.9	70
GSM803592	patient 8, baseline	90.9	65
GSM803595	patient 10, baseline	151.9	74
GSM803598	patient 11, baseline	56	59
GSM803601	patient 12, baseline	97.4	67
GSM803604	patient 13, baseline	75	64
GSM803607	patient 14, baseline	116.1	70
GSM803610	patient 15, baseline	99.7	68
GSM803613	patient 16, baseline	47.9	57
GSM803587	patient 6, arm treated with pimecrolimus	62.9	61
GSM803590	patient 7, arm treated with pimecrolimus	152.2	74
GSM803593	patient 8, arm treated with pimecrolimus	56.6	58
GSM803605	patient 13, arm treated with pimecrolimus	82.1	66
GSM803608	patient 14, arm treated with pimecrolimus	124.5	72
GSM803599	patient 11, arm treated with pimecrolimus	89.3	66
GSM803611	patient 15, arm treated with pimecrolimus	98.2	67
GSM803614	patient 16, arm treated with pimecrolimus	88.9	66
GSM803602	patient 12, arm treated with pimecrolimus	113.3	70
GSM803596	patient 10, arm treated with pimecrolimus	150.7	74
GSM803591	patient 8, arm treated with betamethasone	64	61
GSM803609	patient 15, arm treated with betamethasone	123.2	71
GSM803597	patient 11, arm treated with betamethasone	125.1	71
GSM803585	patient 6, arm treated with betamethasone	107.4	69
GSM803603	patient 13, arm treated with betamethasone	148.6	74
GSM803612	patient 16, arm treated with betamethasone	124.3	71
GSM803588	patient 7, arm treated with betamethasone	98.5	66
GSM803594	patient 10, arm treated with betamethasone	213.2	79
GSM803600	patient 12, arm treated with betamethasone	136.2	73
GSM803606	patient 14, arm treated with betamethasone	149.9	74